Chime N75

Curantil N75: An effective antiplatelet agent for the prevention of thromboembolic complications

Curantil N75 (dipyridamole) is a pharmacological drug from the group of antiplatelet agents produced by Berlin-Chemie AG in Germany. It is widely used to prevent thromboembolic complications and has numerous positive reviews from doctors and patients.

Curantil N75 contains the active ingredient dipyridamole, which has antiplatelet properties. The drug is presented in the form of film-coated tablets containing 75 mg of dipyridamole.

The main indications for the use of Curantil N75 include the prevention of thromboembolic syndrome after heart valve replacement surgery, the prevention of occlusion of stents and coronary artery bypass grafts (in combination with aspirin), the treatment of peripheral vascular lesions, the prevention of placental insufficiency during complicated pregnancy, the treatment and prevention of disseminated intravascular coagulation syndrome in children with infectious toxicosis and septicemia, three-component treatment of glomerulonephritis, platelet suppression syndrome in children, dipyridamole-thallium-201 perfusion scintigraphy with exercise and dipyridamole stress echocardiography.

However, there are some contraindications to the use of Curantil N75. These are increased sensitivity to the drug, acute myocardial infarction, severe atherosclerotic lesions of the coronary vessels with a developed collateral system, predisposition to hypotension, severe intraventricular conduction disorders, severe arterial hypertension, severe liver dysfunction, hemorrhagic diathesis, obstructive pulmonary diseases, II and III trimesters of pregnancy , children and adolescents up to 12 years old.

When using Curantyl N75, some side effects may occur. These may include nausea, abdominal discomfort, facial flushing, coronary steal syndrome (exacerbation of coronary heart disease), headaches, dizziness, bleeding, hypotension, thrombocytopenia, changes in the functional properties of platelets, tachycardia, bradycardia, weakness and rash.

It is important to consider the interactions of Curantyl N75 with other medications. It may enhance the antiplatelet effect of aspirin, anticoagulants (eg, heparin) and thrombolytics. You should also be careful when used simultaneously with digoxin, antiarrhythmic drugs, beta-blockers and nitrates.

When prescribing Curantil N75, you must strictly follow the doctor's recommendations and the dosage specified in the instructions for the drug. Self-medication is not recommended.

In general, Curantil N75 is an effective antiplatelet agent that is widely used for the prevention of thromboembolic complications. However, before using it, you should consult your doctor to evaluate the indications, contraindications and possible side effects in each specific case.